HAART Exposed: Sustiva Causes AIDS Symptoms


Last year, OMSJ identified the HIV drug Sustiva (Efavirenz) as little more than a highly addictive anti-retroviral (ARV) placebo that, when interrupted, produces withdrawal symptoms that AIDS clinicians routinely use to misdiagnose the onset of AIDS.

UPDATE: In 2013, researchers confirmed OMSJ’s analysis.

According to researchers, the following symptoms are known to be caused by HIV, AIDS, or drug withdrawal syndrome:

  • Fever (hyperpyrexia)
  • Soaking night sweats
  • Shaking chills or fever higher than 100 F for several weeks
  • Headache
  • Sore throat
  • Cough and shortness of breath
  • Skin rashes or bumps
  • Chronic diarrhea
  • Weight loss
  • Persistent, unexplained fatigue
  • Blurred and distorted vision

In drug trials involving 202 patients, Sustiva (Efavirenz) was found to cause the following adverse events (AE):

  • Diarrhea (41.4%)
  • Nausea (35.7%)
  • Upper respiratory tract infection (27.6%)
  • Headache (25.2%)
  • Fatigue (23.3%)
  • Pain (22.4%)
  • Influenza-like symptoms (21.0%)

Diarrhea (30.0%) and nausea (29.0%) were the most frequent AEs evaluated as treatment-related as per the investigators.

  • Nineteen subjects discontinued treatment primarily due to one or more AEs according to investigators.
  • One patient died approximately 13 months after starting treatment.
  • Grade 3 (severe) and/or Grade 4 (maximal) AEs occurred in 86 subjects (41.0%; Grade 3: 54, 25.7%; Grade 4: 32, 15.2%).
  • The most frequently reported Grade 3 and Grade 4 AEs were associated with clinical laboratory abnormalities (increased creatine phosphokinase [7.1%], hypertriglyceridemia [6.2%], increased GGT [3.8%], increased amylase [2.9%], bilirubinemia [2.9%], albuminuria [2.4%]), and nausea (2.4%).

Nervous system symptoms, as defined by the sponsor, are of particular interest in subjects receiving efavirenz and include the following: confusion, dizziness, stupor, amnesia, agitation, depersonalization, euphoria, hallucinations, insomnia, somnolence, thinking abnormal, concentration impaired, and dreaming abnormal. In this study, 104 subjects (49.5%) reported a nervous system symptom (see videos below).

Dizziness (19.5%), insomnia (14.8%), and somnolence (11.4%) were reported most frequently. All of the nervous system symptoms were evaluated as mild or moderate, with the exception of one patient with Grade 3 (severe) somnolence, one patient with Grade 3 (severe) confusion, and one patient with Grade 4 (maximal) amnesia. Five subjects permanently discontinued treatment, at least in part, for nervous system symptoms. Three subjects discontinued for dizziness; one patient discontinued for dizziness, insomnia, and hallucination; and one patient discontinued for dizziness and confusion.

Drug Pushers Threaten Patients

When HIV clinicians identify these signs when patients complain of side effects or withdrawal, they typically inform patients that the symptoms are related to HIV or “the onset of AIDS.”  Some clinicians get angry, warning that unless they resume treatment of Sustiva drugs (like Atripla) “they will be dead within months.”  When terrified patients resume their addiction, some of the symptoms subside – leading many to believe that the drug is staving off the effects of AIDS rather than perpetuating a physician-caused addiction.

Daniel Kuritzkes MD

Although OMSJ was on to the Sustiva scam last year, our researchers did not recognize the active components until this week when they discovered that a variety of benzodiazepine antibodies react with the Sustiva metabolite 8-hydroxy efavirenz.

OMSJ determined that use and withdrawal from addictive drugs like cocaine, alcohol, heroin, tobacco THC and benzodiazepine all suppress immune function.  Because smokers, alcoholics and junkies understand the lifesaving properties of a cigarette, martini or cough syrup after a week of abstinence, it’s hard to imagine how Harvard Professor Daniel Kuritzkes MD “didn’t know” that Bristol-Myers Squibb (BMS) scientists manipulated benzodiazepine in HIV drugs for the same reasons that Big Tobacco scientists manipulate nicotine levels in cigarettes.  And while the Justice Department lists marijuana and benzodiazepine as controlled substances, Sustiva isn’t listed.

There’s more.

Keep Reading >>>>>